MBX Biosciences Inc. Comm... (MBX)

NASDAQ: MBX · Real-Time Price · USD

12.04

0.76 (6.74%)

At close: May 02, 2025, 3:59 PM

12.00

-0.37%

After-hours: May 02, 2025, 04:05 PM EDT

MBX Biosciences Common Stock Cash Flow Statement

Financials in USD. Fiscal year is January - December.

Fiscal Year	FY 2024	FY 2023	FY 2022
Period Ending	Dec 31, 2024	Dec 31, 2023	Dec 31, 2022
Net Income	-61.92M	-32.56M	-26.14M
Depreciation & Amortization	244K	157K	56K
Stock-Based Compensation	5.22M	2.04M	306K
Other Working Capital	670K	-1.15M	619K
Other Non-Cash Items	-2.82M	-880K	1.36M
Deferred Income Tax	n/a	n/a	n/a
Change in Working Capital	4.6M	-735K	1.29M
Operating Cash Flow	-54.68M	-31.98M	-23.12M
Capital Expenditures	-874K	-129K	-441K
Cash Acquisitions	n/a	n/a	n/a
Purchase of Investments	-239.47M	-63.8M	-20.22M
Sales Maturities Of Investments	79.75M	33M	9.25M
Other Investing Acitivies	n/a	n/a	n/a
Investing Cash Flow	-160.59M	-30.93M	-11.41M
Debt Repayment	n/a	n/a	10M
Common Stock Repurchased	n/a	n/a	n/a
Dividend Paid	n/a	n/a	n/a
Other Financial Acitivies	-3.94M	709K	-428K
Financial Cash Flow	234.1M	69.22M	46.06M
Net Cash Flow	18.83M	6.31M	11.53M
Free Cash Flow	-55.55M	-32.11M	-23.56M